The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2,2,4,4-Tetramethyl-thiochroman-6-yl)-terephthalamic acid methyl ester ID: ALA139536
PubChem CID: 11740691
Max Phase: Preclinical
Molecular Formula: C22H25NO3S
Molecular Weight: 383.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1ccc(C(=O)Nc2ccc3c(c2)C(C)(C)CC(C)(C)S3)cc1
Standard InChI: InChI=1S/C22H25NO3S/c1-21(2)13-22(3,4)27-18-11-10-16(12-17(18)21)23-19(24)14-6-8-15(9-7-14)20(25)26-5/h6-12H,13H2,1-5H3,(H,23,24)
Standard InChI Key: JZHWLPKXASYCHY-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.8042 -5.1417 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -4.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8000 -3.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -4.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3917 -4.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2875 -4.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8750 -3.9292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4667 -3.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2792 -4.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9125 -3.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9500 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8375 -3.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3542 -4.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3917 -4.8292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9875 -3.3250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8375 -5.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9042 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4292 -4.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9500 -3.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4250 -3.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3542 -4.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4625 -2.4250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2792 -3.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -3.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -5.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6875 -4.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9792 -2.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 2 0
3 9 1 0
4 1 1 0
5 7 1 0
6 1 1 0
7 13 1 0
8 11 1 0
9 6 1 0
10 5 1 0
11 19 2 0
12 2 1 0
13 21 1 0
14 5 2 0
15 8 2 0
16 4 1 0
17 10 1 0
18 10 2 0
19 18 1 0
20 17 2 0
21 16 2 0
22 8 1 0
23 3 1 0
24 3 1 0
25 6 1 0
26 6 1 0
27 22 1 0
2 3 1 0
13 12 2 0
20 11 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.51Molecular Weight (Monoisotopic): 383.1555AlogP: 5.28#Rotatable Bonds: 3Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.15CX LogD: 5.15Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.73Np Likeness Score: -0.65
References 1. Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Fountain KR, Benbrook DM.. (1999) Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors., 42 (21): [PMID:10543887 ] [10.1021/jm990292i ]